Artax Biopharma Granted MHRA Clinical Trial Authorization for AX-158
- Tuesday, July 13, 2021, 7:11
- PR Newswire
- Add a comment
CAMBRIDGE, Mass., July 13, 2021 /PRNewswire/ — Artax Biopharma, Inc., a biotechnology company focused on transforming the treatment of T Cell-mediated diseases, today announced that the United Kingdom’s Medicines and Healthcare Products Regulatory Agency (MHRA) has granted clinical trial…
About the Author
admin has written 20958 stories on this site.